People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...

Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

WEDNESDAY, March 19, 2025 (HealthDay News) -- For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, ...

Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC) and hepatic decompensation among patients with chronic liver disease (CLD ...

Patients with MASLD had nearly twice the all-cause mortality rate as the general population, suggesting the need for multidisciplinary care to reduce excess mortality, researchers said.

For example, damage from the hepatitis B or C virus, or long term alcohol drinking above the recommended levels or non alcoholic fatty liver disease. Hepatocellular carcinoma is more likely to develop ...

The analysis included 16,501 participants: 3610 statin users and 12,891 nonusers. HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for ...